A platform for analyzing diabetes-related data and generating new research hypotheses
Diabetes Data and Hypothesis Hub (D2H2)
This study is creating a helpful online resource for researchers to explore and analyze diabetes-related data, which will also test new compounds to see how they might improve insulin secretion, all aimed at finding better treatments for diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10655363 on NIH RePORTER |
What this research studies
This research aims to create the Diabetes Data and Hypothesis Hub (D2H2), a comprehensive platform that will compile and curate extensive datasets related to diabetes and metabolic disorders. It will provide a user-friendly web portal for researchers to access and analyze these datasets, along with bioinformatics tools to facilitate hypothesis generation. The project will also experimentally test promising compounds identified through data analysis in cell-based assays to evaluate their effects on insulin secretion. Ultimately, this initiative seeks to enhance the understanding of diabetes and lead to new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes or related metabolic disorders who may benefit from new therapeutic approaches.
Not a fit: Patients who do not have diabetes or related metabolic disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatment options for diabetes patients.
How similar studies have performed: Other research initiatives utilizing large datasets and bioinformatics tools have shown promise in advancing diabetes treatment, indicating that this approach could be effective.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Ma'ayan, Avi — Icahn School of Medicine at Mount Sinai
- Study coordinator: Ma'ayan, Avi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.